{"name":"ProLynx LLC","slug":"prolynx-llc","ticker":"","exchange":"","domain":"","description":"ProLynx LLC is a biotechnology company focused on developing innovative treatments for various diseases. The company's lead candidate, PLX038, is currently in Phase 2 clinical trials. ProLynx operates with a lean structure and is dedicated to advancing its pipeline through strategic partnerships and internal research.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOLV9sc1VTQTduSmgzZXpYNldxMmQ1MVBWaExRc3ZfSFp2QklJM3JtLS1CdDRtYWlDaFMxdHB0Y2t3VmRRYUdQemFoMVBzVE1IZHhtYVZ5MEw4blo3Si1RaDJtbFZZNGVPMVlFbGlpX09BLWVOTVRIUDVOZlAyWDlQdW9hZUNRUlZUREhFQWF3NzBRZVVqNGdoLVZWUDd2blhCdmYtaWxNMkNfUQ?oc=5","date":"2026-03-19","type":"pipeline","source":"The Business Journals","summary":"Emeryville biotech lands $70 million to develop monthly weight-loss drug - The Business Journals","headline":"Emeryville biotech lands $70 million to develop monthly weight-loss drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNcTZHTVNLZFJRT3ZoLW5pbkxFN1dobGhKUnQ5ZUpocmIydTZhTXg5bXlYWkQwdTZlMjNnWnZKRlhZdzAtQmdKUF96U0dOY3hodjhhZjlOejBDdlFDUGRvX1BSWklDQnNkRGh2SkRhbVVnOHEzOU9JS2pVbkJpSWJjMFR3S1ljcGFVNkxyamp0aDdlc0U1WFJlZA?oc=5","date":"2025-12-12","type":"pipeline","source":"Fierce Biotech","summary":"Metabolic marketing master maneuvers to CEO—Chutes & Ladders - Fierce Biotech","headline":"Metabolic marketing master maneuvers to CEO—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPdzduVzR5YzE1Mmh0YjYxMHBKY1lfb04zeGl6dFVudmdwUHh2cXFLQWM5Um5EMVM2blpJM2hzbjNFV0NIM190X29iczMteFJFVk9iMDlMb2prSGdLZWZpQ2NMRG5SOF9vdW84b0FoYXN3RHQ0UllVN3Z2NThCOTZkV3d2UlBtRmRsNDRTLTg1WVNnejdSWklnUUk3MnIyVHRaanR1TEhINGtmMjZPX2hwV05XM2RMeHlpcFJWOWVR?oc=5","date":"2025-12-11","type":"pipeline","source":"Fierce Pharma","summary":"Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx - Fierce Pharma","headline":"Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPaC00THRlbjJXQlNqc1lBQXU5c05sMkxHZ1dudl9ad01Hams3ZGx1VF9mUFQ5MUExV1RGQ3BYczhTWkFsYzl4OEpTYWYzNVpkdmNjVE1iYWZVeTRNYUZPZkxLVVgyRGNBNV9pQnJNdnh2Wmw1NVhXYTctQWVjZWtDZ2VFMUo3b3VEcnZTeFBxRjBjQkF5ZGN1bmd6cGVOeG9saTE5WGVQZlpaNFlLNFpIc1E1OFdjd0E4b2M5Nko3dEtYRmlCamc5OEVLSHFFMzd1U2hVMmZwcjVGNW0yN3VOOEdoMExYS0lmMHJMTnA2ajJKUlplSTZCVWU4aw?oc=5","date":"2019-05-02","type":"deal","source":"GlobeNewswire","summary":"ProLynx announces collaboration with Daiichi Sankyo to evaluate drug delivery system in the eye - GlobeNewswire","headline":"ProLynx announces collaboration with Daiichi Sankyo to evaluate drug delivery system in the eye","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}